Know the status of your medication? Check Now

SEMAGLUTIDE

SEMAGLUTIDE, a GLP-1 analogue, is placed on the WADA 2024 Monitoring Program in order to detect patterns of misuse in sport IN- AND OUT-OF-COMPETITION.